Drug

Capmatinib

53 flagged reaction(s) · 2,389 total co-reports · max PRR 23.3

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Generalised Oedema	32	23.3	23.6	signal
2	Oedema	134	22.2	23.5	signal
3	Product Use Complaint	32	18.5	18.7	signal
4	Oedema Peripheral	245	17.9	19.9	signal
5	Peripheral Swelling	288	16.8	19.0	signal
6	Metastases To Central Nervous System	24	16.8	16.9	signal
7	Malignant Neoplasm Progression	180	15.8	17.1	signal
8	Hepatic Cytolysis	21	15.4	15.5	signal
9	Blood Calcium Decreased	16	12.7	12.8	signal
10	Deafness	36	12.3	12.5	signal
11	Blood Potassium Increased	17	9.4	9.4	signal
12	Hypoacusis	44	9.2	9.3	signal
13	Fluid Retention	52	9.2	9.3	signal
14	Lung Neoplasm Malignant	42	9.1	9.2	signal
15	Blood Creatinine Increased	66	9.0	9.3	signal
16	Hepatotoxicity	22	8.9	9.0	signal
17	Pleural Effusion	58	8.5	8.7	signal
18	Pneumonitis	25	8.3	8.4	signal
19	Metastases To Bone	15	8.2	8.3	signal
20	Blood Urea Increased	15	8.0	8.0	signal
21	Dysphagia	83	7.8	8.1	signal
22	Joint Swelling	92	6.8	7.1	signal
23	Conjunctivitis	14	6.8	6.9	signal
24	Brain Neoplasm	7	6.8	6.8	signal
25	Neoplasm	8	6.2	6.2	signal
26	Product Availability Issue	15	6.0	6.0	signal
27	Taste Disorder	13	5.8	5.8	signal
28	Pulmonary Thrombosis	7	5.7	5.7	signal
29	Blood Sodium Decreased	12	5.7	5.7	signal
30	Swelling	59	5.7	5.8	signal
31	Therapy Change	6	5.6	5.6	signal
32	Liver Function Test Increased	13	5.5	5.5	signal
33	Gynaecomastia	19	5.4	5.5	signal
34	Metastases To Lung	7	5.4	5.4	signal
35	Red Blood Cell Count Decreased	17	5.3	5.3	signal
36	Neoplasm Malignant	36	4.8	4.9	signal
37	Metastases To Liver	9	4.6	4.6	signal
38	Central Nervous System Lesion	7	4.5	4.5	signal
39	Glomerular Filtration Rate Decreased	6	4.4	4.4	signal
40	Death	414	4.3	5.0	signal
41	Thrombosis	38	4.2	4.3	signal
42	Drug Resistance	12	4.2	4.2	signal
43	Hepatic Function Abnormal	16	3.9	3.9	signal
44	Hospice Care	4	3.6	3.6	signal
45	Disease Progression	47	3.6	3.6	signal
46	Therapy Partial Responder	6	3.6	3.6	signal
47	Increased Appetite	7	3.3	3.3	signal
48	Choking	7	3.2	3.2	signal
49	Face Oedema	6	3.2	3.2	signal
50	Neoplasm Progression	11	2.8	2.8	signal
51	Therapy Interrupted	19	2.5	2.5	signal
52	Product Physical Issue	5	2.2	2.2	no signal
53	Oesophageal Carcinoma	3	0.9	0.9	no signal